Accenture (ACN) Competitors

Accenture logo
$126.71 +1.88 (+1.51%)
Closing price 03:58 PM Eastern
Extended Trading
$126.75 +0.04 (+0.03%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ACN vs. CAR, CCRN, CRAI, CTSH, and NVDA

Should you buy Accenture stock or one of its competitors? MarketBeat compares Accenture with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Accenture include Avis Budget Group (CAR), Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Cognizant Technology Solutions (CTSH), and NVIDIA (NVDA).

How does Accenture compare to Avis Budget Group?

Accenture (NYSE:ACN) and Avis Budget Group (NASDAQ:CAR) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

75.1% of Accenture shares are owned by institutional investors. Comparatively, 96.4% of Avis Budget Group shares are owned by institutional investors. 0.0% of Accenture shares are owned by insiders. Comparatively, 50.5% of Avis Budget Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Accenture has higher revenue and earnings than Avis Budget Group. Avis Budget Group is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.21$7.68B$12.5210.12
Avis Budget Group$11.65B0.58-$889M-$19.05N/A

Accenture presently has a consensus target price of $196.85, indicating a potential upside of 55.36%. Avis Budget Group has a consensus target price of $131.50, indicating a potential downside of 30.96%. Given Accenture's stronger consensus rating and higher possible upside, research analysts plainly believe Accenture is more favorable than Avis Budget Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
14 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.50
Avis Budget Group
4 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.60

Accenture has a net margin of 10.66% compared to Avis Budget Group's net margin of -5.68%. Accenture's return on equity of 26.47% beat Avis Budget Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.66% 26.47% 12.89%
Avis Budget Group -5.68%N/A -0.47%

Accenture has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, Avis Budget Group has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

In the previous week, Accenture had 103 more articles in the media than Avis Budget Group. MarketBeat recorded 111 mentions for Accenture and 8 mentions for Avis Budget Group. Avis Budget Group's average media sentiment score of 1.19 beat Accenture's score of 0.39 indicating that Avis Budget Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accenture
39 Very Positive mention(s)
11 Positive mention(s)
26 Neutral mention(s)
19 Negative mention(s)
3 Very Negative mention(s)
Neutral
Avis Budget Group
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Accenture beats Avis Budget Group on 11 of the 15 factors compared between the two stocks.

How does Accenture compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Accenture (NYSE:ACN) are related companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Accenture has a net margin of 10.66% compared to Cross Country Healthcare's net margin of -9.84%. Accenture's return on equity of 26.47% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-9.84% -0.74% -0.54%
Accenture 10.66%26.47%12.89%

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 75.1% of Accenture shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.0% of Accenture shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Accenture had 109 more articles in the media than Cross Country Healthcare. MarketBeat recorded 111 mentions for Accenture and 2 mentions for Cross Country Healthcare. Accenture's average media sentiment score of 0.39 beat Cross Country Healthcare's score of 0.00 indicating that Accenture is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Accenture
39 Very Positive mention(s)
11 Positive mention(s)
26 Neutral mention(s)
19 Negative mention(s)
3 Very Negative mention(s)
Neutral

Accenture has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.05B0.40-$94.85M-$3.05N/A
Accenture$69.67B1.21$7.68B$12.5210.12

Cross Country Healthcare currently has a consensus target price of $12.05, suggesting a potential downside of 8.64%. Accenture has a consensus target price of $196.85, suggesting a potential upside of 55.36%. Given Accenture's stronger consensus rating and higher possible upside, analysts clearly believe Accenture is more favorable than Cross Country Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90
Accenture
0 Sell rating(s)
14 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.50

Cross Country Healthcare has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Accenture has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

Summary

Accenture beats Cross Country Healthcare on 13 of the 15 factors compared between the two stocks.

How does Accenture compare to Charles River Associates?

Accenture (NYSE:ACN) and Charles River Associates (NASDAQ:CRAI) are related companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Accenture has a net margin of 10.66% compared to Charles River Associates' net margin of 6.22%. Accenture's return on equity of 26.47% beat Charles River Associates' return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.66% 26.47% 12.89%
Charles River Associates 6.22%26.02%8.35%

In the previous week, Accenture had 111 more articles in the media than Charles River Associates. MarketBeat recorded 111 mentions for Accenture and 0 mentions for Charles River Associates. Accenture's average media sentiment score of 0.39 beat Charles River Associates' score of 0.00 indicating that Accenture is being referred to more favorably in the media.

Company Overall Sentiment
Accenture Neutral
Charles River Associates Neutral

Accenture has higher revenue and earnings than Charles River Associates. Accenture is trading at a lower price-to-earnings ratio than Charles River Associates, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.21$7.68B$12.5210.12
Charles River Associates$751.58M1.24$54.78M$7.2020.01

75.1% of Accenture shares are owned by institutional investors. Comparatively, 84.1% of Charles River Associates shares are owned by institutional investors. 0.0% of Accenture shares are owned by company insiders. Comparatively, 4.5% of Charles River Associates shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Accenture presently has a consensus price target of $196.85, indicating a potential upside of 55.36%. Charles River Associates has a consensus price target of $245.00, indicating a potential upside of 70.06%. Given Charles River Associates' higher possible upside, analysts plainly believe Charles River Associates is more favorable than Accenture.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
14 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.50
Charles River Associates
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Charles River Associates has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 5.1%. Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.6%. Accenture pays out 52.1% of its earnings in the form of a dividend. Charles River Associates pays out 31.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has raised its dividend for 20 consecutive years and Charles River Associates has raised its dividend for 7 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Accenture beats Charles River Associates on 12 of the 18 factors compared between the two stocks.

How does Accenture compare to Cognizant Technology Solutions?

Accenture (NYSE:ACN) and Cognizant Technology Solutions (NASDAQ:CTSH) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

75.1% of Accenture shares are owned by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are owned by institutional investors. 0.0% of Accenture shares are owned by company insiders. Comparatively, 0.4% of Cognizant Technology Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Accenture has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Cognizant Technology Solutions has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

Accenture presently has a consensus price target of $196.85, indicating a potential upside of 55.36%. Cognizant Technology Solutions has a consensus price target of $71.64, indicating a potential upside of 74.94%. Given Cognizant Technology Solutions' higher probable upside, analysts clearly believe Cognizant Technology Solutions is more favorable than Accenture.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
14 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.50
Cognizant Technology Solutions
0 Sell rating(s)
13 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Accenture had 86 more articles in the media than Cognizant Technology Solutions. MarketBeat recorded 111 mentions for Accenture and 25 mentions for Cognizant Technology Solutions. Cognizant Technology Solutions' average media sentiment score of 1.09 beat Accenture's score of 0.39 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accenture
39 Very Positive mention(s)
11 Positive mention(s)
26 Neutral mention(s)
19 Negative mention(s)
3 Very Negative mention(s)
Neutral
Cognizant Technology Solutions
13 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Accenture has a net margin of 10.66% compared to Cognizant Technology Solutions' net margin of 10.41%. Accenture's return on equity of 26.47% beat Cognizant Technology Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.66% 26.47% 12.89%
Cognizant Technology Solutions 10.41%17.50%12.94%

Accenture has higher revenue and earnings than Cognizant Technology Solutions. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.21$7.68B$12.5210.12
Cognizant Technology Solutions$21.11B0.92$2.23B$4.608.90

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 5.1%. Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 3.2%. Accenture pays out 52.1% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has raised its dividend for 20 consecutive years and Cognizant Technology Solutions has raised its dividend for 6 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Accenture beats Cognizant Technology Solutions on 13 of the 19 factors compared between the two stocks.

How does Accenture compare to NVIDIA?

NVIDIA (NASDAQ:NVDA) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, NVIDIA had 220 more articles in the media than Accenture. MarketBeat recorded 331 mentions for NVIDIA and 111 mentions for Accenture. NVIDIA's average media sentiment score of 0.99 beat Accenture's score of 0.39 indicating that NVIDIA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NVIDIA
234 Very Positive mention(s)
28 Positive mention(s)
39 Neutral mention(s)
21 Negative mention(s)
8 Very Negative mention(s)
Positive
Accenture
39 Very Positive mention(s)
11 Positive mention(s)
26 Neutral mention(s)
19 Negative mention(s)
3 Very Negative mention(s)
Neutral

NVIDIA has a net margin of 62.97% compared to Accenture's net margin of 10.66%. NVIDIA's return on equity of 96.94% beat Accenture's return on equity.

Company Net Margins Return on Equity Return on Assets
NVIDIA62.97% 96.94% 72.16%
Accenture 10.66%26.47%12.89%

NVIDIA has higher revenue and earnings than Accenture. Accenture is trading at a lower price-to-earnings ratio than NVIDIA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NVIDIA$215.94B22.41$120.07B$6.5330.63
Accenture$69.67B1.21$7.68B$12.5210.12

NVIDIA pays an annual dividend of $1.00 per share and has a dividend yield of 0.5%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 5.1%. NVIDIA pays out 15.3% of its earnings in the form of a dividend. Accenture pays out 52.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. NVIDIA has increased its dividend for 1 consecutive years and Accenture has increased its dividend for 20 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

65.3% of NVIDIA shares are owned by institutional investors. Comparatively, 75.1% of Accenture shares are owned by institutional investors. 3.9% of NVIDIA shares are owned by insiders. Comparatively, 0.0% of Accenture shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

NVIDIA presently has a consensus price target of $305.67, suggesting a potential upside of 52.83%. Accenture has a consensus price target of $196.85, suggesting a potential upside of 55.36%. Given Accenture's higher probable upside, analysts plainly believe Accenture is more favorable than NVIDIA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NVIDIA
0 Sell rating(s)
3 Hold rating(s)
48 Buy rating(s)
3 Strong Buy rating(s)
3.00
Accenture
0 Sell rating(s)
14 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.50

NVIDIA has a beta of 2.22, indicating that its stock price is 122% more volatile than the broader market. Comparatively, Accenture has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

Summary

NVIDIA beats Accenture on 15 of the 20 factors compared between the two stocks.

Get Accenture News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACN vs. The Competition

MetricAccentureIT Services IndustryComputer SectorNYSE Exchange
Market Cap$83.07B$11.63B$38.14B$23.15B
Dividend Yield5.22%2.71%3.26%4.06%
P/E Ratio9.1144.4179.3931.08
Price / Sales1.216.52616.25108.25
Price / Cash7.6423.4648.3318.65
Price / Book2.553.159.644.65
Net Income$7.68B$534.00M$1.07B$1.07B
7 Day Performance-23.60%-6.61%-1.41%-1.04%
1 Month Performance-29.35%-6.78%0.99%0.18%
1 Year Performance-57.05%-21.61%159.21%24.25%

Accenture Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACN
Accenture
4.8852 of 5 stars
$126.71
+1.5%
$196.85
+55.4%
-56.4%$83.07B$69.67B10.12779,000
CAR
Avis Budget Group
2.1269 of 5 stars
$190.07
+1.6%
$129.63
-31.8%
+38.6%$6.72B$11.65BN/A25,000
CCRN
Cross Country Healthcare
1.9161 of 5 stars
$13.17
flat
$12.05
-8.5%
-6.1%$425.83M$1.00BN/A6,784
CRAI
Charles River Associates
4.4238 of 5 stars
$147.75
-1.8%
$245.00
+65.8%
-22.0%$954.47M$751.58M20.52940
CTSH
Cognizant Technology Solutions
4.9269 of 5 stars
$50.82
-2.6%
$73.50
+44.6%
-44.6%$24.08B$21.11B11.05351,600

Related Companies and Tools


This page (NYSE:ACN) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners